EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

L-Arginine and Its Metabolites in Age-Related Cerebral Small Vessel Disease with Cognitive Impairment

Larisa Dobrynina iD, Alexandra Byrochkina, Kamila Shamtieva, Elena Kremneva iD, Maryam Zabitova iD, Alla Shabalina

Biomolecules · 19.06.2026 · 16 (6) · 914

DOI: 10.3390/biom16060914 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 19.06.2026. Verfasst von Larisa Dobrynina und 5 weiteren Autor:innen. Beteiligte Einrichtung: Russian Center of Neurology and Neurosciences, 125367 Moscow, Russia. Hauptthemen laut MEDLINE: Arginine, Cerebral Small Vessel Diseases, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A key mechanism in the pathogenesis of cerebral small vessel disease (CSVD) is endothelial dysfunction associated with impaired metabolism of nitric oxide (NO) and its main substrate, L-arginine. The aim of the study was to assess parameters of L-arginine metabolism and their association with MRI-defined brain damage in CSVD patients. A total of 100 CSVD patients (according to MRI STRIVE standards) and cognitive impairment (CI) of varying severity, as well as 20 healthy volunteers, were analyzed. Levels of L-arginine and its metabolites—L-ornithine, L-citrulline, and asymmetric dimethylarginine (ADMA)—were measured; diffusion tensor MRI, MRI volumetry, and morphometry were performed. A threshold level of L-arginine (51.25 μmol/L) was identified, above which an association with CI was observed. Patients with L-arginine ≥ 51.25 μmol/L demonstrated poorer performance on cognitive tests (Stroop test, trail-making test (TMT)-B, TMT B–A, 10-word test) and more severe brain damage, reflected by greater severity of MRI markers (white matter hyperintensities, microbleeds), changes in brain component volumes, cortical atrophy in specific regions, and impairment of white matter microstructural integrity. The obtained data indicate a pathogenetic link between disturbances in L-arginine homeostasis and the development of CSVD with CI and support the need for further studies aimed at refining approaches to their correction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArginineCerebral Small Vessel DiseasesCognitive DysfunctionHumansFemaleMaleAgedMiddle AgedMagnetic Resonance ImagingAging

Stichwörter der Autor:innen

L-arginineMRI morphometryMRI volumetrycerebral small vessel diseasediffusion tensor MRImild cognitive impairmentsubjective cognitive impairment

Substanzen

Arginine

Autor:innen und Institutionen

  • Russian Center of Neurology and Neurosciences, 125367 Moscow, Russia.

ORCID-Profile: Larisa Dobrynina, Elena Kremneva, Maryam Zabitova

Förderung

  • Russian Science Foundation

Zitieren

APA

Dobrynina, L., Byrochkina, A., Shamtieva, K., Kremneva, E., Zabitova, M., & Shabalina, A. (2026). L-Arginine and Its Metabolites in Age-Related Cerebral Small Vessel Disease with Cognitive Impairment. Biomolecules, 16(6), 914. https://doi.org/10.3390/biom16060914

Vancouver

Dobrynina L, Byrochkina A, Shamtieva K, Kremneva E, Zabitova M, Shabalina A. L-Arginine and Its Metabolites in Age-Related Cerebral Small Vessel Disease with Cognitive Impairment. Biomolecules. 2026;16(6):914. doi:10.3390/biom16060914

BibTeX
@article{Dobrynina2026,
  author = {Dobrynina, Larisa and Byrochkina, Alexandra and Shamtieva, Kamila and Kremneva, Elena and Zabitova, Maryam and Shabalina, Alla},
  title = {L-Arginine and Its Metabolites in Age-Related Cerebral Small Vessel Disease with Cognitive Impairment},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {914},
  doi = {10.3390/biom16060914}
}
Kostenlos starten →